Guy P Nohra's Net Worth

$205 Million

Estimate Recalculated Jul 16, 2024 06:07PM EST

Who is Guy P Nohra?

Guy P Nohra has an estimated net worth of $205 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., COTHERIX INC, ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., RENOVIS INC, ATS MEDICAL INC, CUTERA INC, DYNAVAX TECHNOLOGIES CORP, NeurogesX Inc, RIGEL PHARMACEUTICALS INC, ACELRX PHARMACEUTICALS INC, XCYTE THERAPIES INC, ICAGEN INC, FLAMEL TECHNOLOGIES SA, INTARCIA THERAPEUTICS, INC, TorreyPines Therapeutics, Inc., CRUCELL NV, OCCAM NETWORKS INC/DE, AERIE PHARMACEUTICALS INC, ELLIE MAE INC, Bioventus Inc., and Carbylan Therapeutics, Inc..

SEC CIK

Guy P Nohra's CIK is 0001198330

Past Insider Trading and Trends

2014 was Guy P Nohra's most active year for acquiring shares with 29 total transactions. Guy P Nohra's most active month to acquire stocks was the month of January. 2004 was Guy P Nohra's most active year for disposing of shares, totalling 84 transactions. Guy P Nohra's most active month to dispose stocks was the month of March. 2007 saw Guy P Nohra paying a total of $16,415,000.00 for 13,498,673 shares, this is the most they've acquired in one year. In 2003 Guy P Nohra cashed out on 3,325,000 shares for a total of $63,177,849.99, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CUTERA INC (CUTR) Snapshot price: $2.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.74K
$23.33
-$40,524.21
0
Aug 15
Form 4
—
0
—
—
0
Jun 8
Form 4
-99.83%
-1.00M
—
—
1.74K
Feb 22
Form 4
—
0
—
—
0
May 10
Form 4
∞
1M
—
—
1M
Apr 5
Form 3
—
0
—
—
0
No matching records found

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.955

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-98.98%
-1.51M
—
—
15.52K
Feb 23
No matching records found

RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $1.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-47.60%
-769.64K
$21.11
-$16,450,387.86
847.09K
Aug 20
Form 4
-0.85%
-3.10K
$21.50
-$66,650.00
360.48K
May 7
Form 4
-20.75%
-95.20K
$21.31
-$2,028,397.84
363.58K
May 3
Form 4
-1.80%
-8.40K
$21.25
-$178,500.00
458.78K
Apr 30
Form 4
-4.23%
-42.80K
$21.25
-$909,513.92
969.17K
Apr 28 - Apr 29
Form 4
-0.86%
-8.90K
$21.26
-$189,180.16
1.03M
Apr 26 - Apr 27
Form 4
-2.46%
-13.10K
$21.32
-$279,285.45
518.88K
Apr 23
Form 4
-0.82%
-8.80K
$21.26
-$187,122.13
1.07M
Apr 21 - Apr 22
Form 4
-10.03%
-60.30K
$21.00
-$1,266,342.21
540.78K
Apr 7
Form 4
-0.89%
-10.90K
$21.98
-$231,240.00
1.21M
Apr 5 - Apr 6
Form 4
-1.21%
-7.49K
$20.00
-$149,740.00
611.98K
Mar 24
Form 4/A
-10.73%
-74.46K
$20.00
-$1,489,280.00
619.47K
Feb 19
Form 4
-16.10%
-111.70K
$20.00
-$2,233,920.00
582.24K
Feb 19
Form 4
-16.10%
-111.70K
$20.00
-$2,233,920.00
582.24K
Feb 19
No matching records found

XCYTE THERAPIES INC (CYCC) Snapshot price: $2.3718

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 3
Form 4/A
∞
1.14M
$8.00
$1,000,000.00
1.14M
Mar 19
Form 4
∞
1.14M
$8.00
$1,000,000.00
1.14M
Mar 16 - Mar 19
Form 3/A
—
0
—
—
0
No matching records found

ICAGEN INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.14M
—
—
2.14M
Feb 8
Form 3
—
0
—
—
0
No matching records found